<DOC>
	<DOCNO>NCT00111644</DOCNO>
	<brief_summary>This study ass efficacy safety intravenous beta-lactam , comparison ceftriaxone , hospitalized patient community-acquired pneumonia cause Legionella . The anticipated time study treatment 3-12 month target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study Assess Beta-Lactam Treatment Hospitalized Patients With Bacterial Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<criteria>male female patient least 18 year age ; hospitalization communityacquired pneumonia development pneumonia within 48 hour hospitalize another reason ; fever ; new increase productive cough ; chest pain , shortness breath , rapid breathing . require intubation ventilation ; nursing home extend care within 60 day study ; concomitant bacterial infection require antibiotic ; longterm immunosuppressive therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>